AI Summary & Key Takeaways
AI InsightAs a conclusion pseudothrombocytopenia should be excluded in all thrombocytopenic patients without any hemorrhagic tendency by manual peripheric smear to avoid unnecessary diagnostic tests and wrong treatments.
📌 3 Key Takeaways
Abstract
EDTA-dependent pseudothrombocytopenia (EDTA-PTCP) is a phenomenon caused by EDTA- dependent anti-platelet antibody. It is necessary for clinicians to consider the possible presence of PTCP in cases of patients having low platelet counts without any hemorrhagic tendency. We here present a EDTA-dependent pseudothromboctyopenia case which might be associated with rheumatoid arthritis and/or the medications such as sulfasalazine, leflunomide and methylprednisolone. As a conclusion pseudothrombocytopenia should be excluded in all thrombocytopenic patients without any hemorrhagic tendency by manual peripheric smear to avoid unnecessary diagnostic tests and wrong treatments.
Özet
EDTAbağımlıpseudotrombositopeni(EDTA-PTCP),EDTA'yabağlı antitrombosit antikorlarının varlığı nedeniyle oluşur. Herhangi bir kanama bulgusu olmayan trombositopenik olgularda EDTA-PTCP mutlaka akılda tutulmalıdır. Biz de sülfasalazin, leflunomide ve metilprednizolon tedavisi alan ileri yaştaki romatoid artrit olgusunda, hastalık ve/veya ilaçlara bağlı EDTA-PTCP durumunu sunmak istedik. Trombositopenik olguların periferik yayma ile değerlendirilerek pseudotrombositopeninin ekarte edilmesi gereksiz test ve tedavileri önlemesi açısından önemlidir.